Proton Therapy for Peripheral Lymph Nodes in Breast Cancer
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Collection and Analyzation of Dosimetric Information
Determine whether proton therapy will reduce the volume of heart exposed to radiation doses ≥ 5 Gy/Cobalt Gray Equivalent by at least 50% compared with conventional planning.
2 weeks prior to starting radiation therapy.
Julie A Bradley, MD
University of Florida Proton Therapy Institute
United States: Institutional Review Board
|University of Florida Proton Therapy Institute||Jacksonville, Florida 32206|